ClinicalTrials.Veeva

Menu

Cognitive Behavioral Therapy(CBT) in Treatment of Methamphetamine Use Disorder

A

Assiut University

Status

Not yet enrolling

Conditions

Methamphetamine Abuse

Treatments

Behavioral: cognitive behavioral therapy

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

The efficacy of cognitive behavioral therapy(CBT) in treatment of methamphetamine use disorder

Full description

Methamphetamine (MA) use is a serious public health concern in many countries and is second to cannabis as the most widely abused illicit drug in the world.

Over the past few years; there is an alarming increase in crystal methamphetamine (Shabu) abuse in the Egyptian market and The Egyptian government is annoyed from this issue because youth within the age of productivity were targeted.

Regular methamphetamine use can be associated with a range of psychiatric symptoms, particularly psychosis, anxiety, and depression.

No FDA approved pharmacological treatments are available for Meth addiction up till now and despite great advances achieved in understanding the neurobiology of drug addiction, the therapeutic options are severely limited . Consequently, the only available treatment at present is psychosocial intervention.

The effectiveness of CBT for other substance-use disorders (e.g. alcohol-, opioid- and cocaine-use disorders) has been well documented and as such this basic treatment approach has been applied to amphetamine-type stimulant (ATS)-use disorder .

Currently, there is not enough evidence to establish the efficacy of CBT for amphetamine -type stimulant( ATS) -use disorders because of a paucity of high-quality research in this area.

The present study will examine the efficacy of Cognitive behavioral therapy in reducing methamphetamine use in comparison to medical treatment usually taken in methamphetamine use disorder

Enrollment

50 estimated patients

Sex

Male

Ages

15 to 50 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patients who meet the criteria for methamphetamine use disorder according to Diagnostic and Statistical Manual of Mental Disorders Fifth Edition (DSM 5) (10)
  • aged of 15-49 years' old
  • more than 9 year of education
  • urine drug screening positive for methamphetamine

Exclusion criteria

  • other Axis I disorder of DSM-V criteria such as bipolar disorder, schizophrenia, depression
  • Had a legal case pending resulting in inability to commit to 12 weeks of treatment.
  • Refusal to participate
  • poly drug dependence.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

50 participants in 2 patient groups

treatment-as-usual (TAU)
Active Comparator group
Treatment:
Behavioral: cognitive behavioral therapy
Clinician-delivered CBT with tratment as usual
Active Comparator group
Treatment:
Behavioral: cognitive behavioral therapy

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems